|
TRUB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.392500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.842840E-03 |
| Normal-vs-Stage2 |
4.070300E-02 |
| Normal-vs-Stage3 |
2.826900E-04 |
| Normal-vs-Stage4 |
7.91489999985018E-07 |
| Stage1-vs-Stage2 |
6.407600E-01 |
| Stage1-vs-Stage3 |
2.007200E-01 |
| Stage1-vs-Stage4 |
5.720100E-03 |
| Stage2-vs-Stage3 |
2.049800E-01 |
| Stage2-vs-Stage4 |
8.597800E-03 |
| Stage3-vs-Stage4 |
1.060620E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.563100E-04 |
| Normal-vs-AfricanAmerican |
1.747360E-01 |
| Normal-vs-Asian |
1.967090E-04 |
| Caucasian-vs-AfricanAmerican |
2.670400E-01 |
| Caucasian-vs-Asian |
3.950200E-01 |
| AfricanAmerican-vs-Asian |
1.191590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.05540000000715E-06 |
| Normal-vs-Female |
1.761730E-03 |
| Male-vs-Female |
3.442200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.277600E-03 |
| Normal-vs-Age(41-60Yrs) |
9.81679999999541E-05 |
| Normal-vs-Age(61-80Yrs) |
9.016600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.430980E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.384210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.565000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.665000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.488800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.600800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.564800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.451800E-01 |
| Classical-VS-Follicular |
2.294400E-01 |
| Classical-VS-Other |
3.577200E-01 |
| Classical-VS-Normal |
5.615000E-04 |
| Tall-VS-Follicular |
1.986360E-01 |
| Tall-VS-Other |
5.832400E-01 |
| Tall-VS-Normal |
2.859800E-03 |
| Follicular-VS-Other |
2.555000E-01 |
| Follicular-VS-Normal |
5.445700E-02 |
| Other-VS-Normal |
2.719700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.021530E-03 |
| Normal-vs-N1 |
1.446460E-04 |
| N0-vs-N1 |
1.709830E-01 |
|
|
